Startups channel feed – Endpoints News

Startups channel feed

Food-sourced microbiome drugs get $101M megaround for Flagship's Kaleido

7 years ago

Akero elbows its way into a crowded NASH field, with $65M and a strategy for tackling a blockbuster market

7 years ago

UK startup NodThera banks a $40M round with plans to conquer a closely-studied inflammatory target

7 years ago

J&J opens up a new biotech incubator, polishing the Big Apple's ambitions to create a major hub

7 years ago

With an AstraZeneca cancer drug in one hand, $37M in the other, Shanghai's Alpha Bio zooms into a PhII study

7 years ago

I/O player iTeos lines up a $75M round as it preps for human studies, plans a leap to US hub

7 years ago

Sound familiar? China/US biotech hybrid lands rights to cancer drugs, cash and a team of development vets to launch Oncologie

7 years ago

Rich Heyman's Metacrine tacks on another $65M to tackle a superior NASH drug

7 years ago

This startup CEO swiftly gained $260M and a dream team of biotech backers — on both sides of the Pacific

8 years ago

30-year Gilead R&D vet Norbert Bischofberger is starting over as staffer #5 at an upstart biotech — and he’s loving it

8 years ago

Versant backs new approach to gamma delta T cells, co-leads Lava's $18.9M round

8 years ago

Bay Area startup Rain Therapeutics nabs $18M Series A to target lung cancer niche

8 years ago

Forget RNA drugs. Accent gets $40M to develop small molecules that modify RNA instead

8 years ago

Seattle's Nohla closes $45M to bring novel stem cell treatment for leukemia to late-stage trials

8 years ago

Third Rock, GV back Broad spinout Celsius in bid to develop precision meds for autoimmune disease

8 years ago

CRISPR trailblazers Zhang, Liu and Joung join forces to launch Beam with $87M and cutting-edge gene-editing tech

8 years ago

Eight years after Eli Lilly dumped it, an upstart biotech has nabbed teplizumab and filed a $56M IPO to back a PhIII comeback

8 years ago

Ex-Receptos CTO co-founds SD startup Escient, launching with $40M Series A

8 years ago

Third Rock sinks $59M into Casma's 'recycling' tech, with neuro on the mind

8 years ago

Chinese investors back Refuge Bio’s $25M B round as it steers gene engineering tech to an IND

8 years ago

Out to ‘rethink the drug design process,’ AI star Daphne Koller is creating a new machine learning venture at insitro with some heavyweight backers

8 years ago

Omega Funds leads $35M Series A to fuel Attenua's cough program, set for proof-of-concept this year

8 years ago

IL-2 without the toxic side effects? Orbimed backs the idea in Synthorx' $63M round

8 years ago

CRISPR legend Jennifer Doudna helps some recent college grads launch a diagnostics upstart

8 years ago

First page Previous page 63 64 656667 68 69 Next page Last page